Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic. - Strojnik K; Blatnik A; Krajc M; Novaković A; Ignjatović M; Ocvirk J; Stegel V; Škerl P; Klančar G; Novaković S; Šetrajčič Dragoš V (BJC reports, 2026)